e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis
Faria Nasim, Teng Moua
Source:
ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020
Journal Issue:
October
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Faria Nasim, Teng Moua. Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis. ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung cancer associated pulmonary embolism: Retrospective analysis
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
Longitudinal assessment in combined pulmonary fibrosis and emphysema (CPFE): a case series
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
Source: ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018
Year: 2019
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020
The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014
Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis
Source: International Congress 2019 – Medical education
Year: 2019
Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort
Source: Eur Respir J, 49 (5) 1601162; 10.1183/13993003.01162-2016
Year: 2017
Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study
Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018
Year: 2019
Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe.
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021
Prospective study of feasibility and safety of bronchoscopic transbronchial cryprobe biopsies in interstitial lung disease: Initial experience of an Irish interstitial lung disease centre
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment I
Year: 2016
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Treatment dilemmas in sarcoidosis - a retrospective cohort study
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Bronchial colonisation in patients with lung cancer: a prospective study
Source: Eur Respir J 2013; 42: 220-229
Year: 2013
Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients
Source: International Congress 2014 – ILDs 6
Year: 2014
Pirfenidone as a treatment for asbestos-related lung fibrosis? A retrospective case series
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept